Pharmacological characterization of human S1P4 using a novel radioligand, [4,5-3H]-dihydrosphingosine-1-phosphate

被引:9
作者
Fossetta, J
Deno, G
Gonsiorek, W
Fan, XD
Lavey, B
Das, P
Lunn, C
Zavodny, PJ
Lundell, D
Hipkin, RW
机构
[1] Schering Plough Corp, Res Inst, Dept Inflammat & Infect Dis, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, Res Inst, Dept Chem, Kenilworth, NJ 07033 USA
关键词
sphingosine-1-phosphate; dihydrosphingosine-1-phosphate; S1P(4);
D O I
10.1038/sj.bjp.0705856
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Sphingosine-1-phosphate (S1P) is a bioactive lipid that affects a variety of cellular processes through both its actions as a second messenger and via activation of a family of G protein-coupled receptors (S1P(1-5)). 2 The study of S1P receptor pharmacology, particularly S1P(4), has been hindered by the lack of high-affinity radioligands with good specific activity. The studies presented herein characterize [H-3] DH-S1P as a stable, high-affinity radioligand for S1P(4) pharmacology. 3 Using a transfected Ba/F3 cell line selected for high hS1P(4) surface expression, we compared the consequences of different cellular backgrounds and commercial sources of sphingophospholipids on S1P4 characterization. The development and subsequent use of the assay described has enabled us to extensively and definitively characterize the pharmacology of the human S1P(4) receptor.
引用
收藏
页码:851 / 860
页数:10
相关论文
共 29 条
[1]   G-protein-coupled receptor stimulation of the p42/p44 mitogen-activated protein kinase pathway is attenuated by lipid phosphate phosphatases 1, 1a, and 2 in human embryonic kidney 293 cells [J].
Alderton, F ;
Darroch, P ;
Sambi, B ;
McKie, A ;
Ahmed, IS ;
Pyne, N ;
Pyne, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :13452-13460
[2]  
An SZ, 1999, MOL PHARMACOL, V55, P787
[3]   THE EFFECT OF GM-CSF AND G-CSF ON HUMAN NEUTROPHIL FUNCTION [J].
BOBER, LA ;
GRACE, MJ ;
PUGLIESESIVO, C ;
ROJASTRIANA, A ;
WATERS, T ;
SULLIVAN, LM ;
NARULA, SK .
IMMUNOPHARMACOLOGY, 1995, 29 (02) :111-119
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]  
Candelore MR, 2002, BIOCHEM BIOPH RES CO, V297, P600
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature [J].
Chun, J ;
Goetzl, EJ ;
Hla, T ;
Igarashi, Y ;
Lynch, KR ;
Moolenaar, W ;
Pyne, S ;
Tigyi, G .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :265-269
[8]   Human interferon-inducible 10-kDa protein and human interferon-inducible T cell α chemoattractant are allotopic ligands for human CXCR3:: Differential binding to receptor states [J].
Cox, MA ;
Jenh, CH ;
Gonsiorek, W ;
Fine, J ;
Narula, SK ;
Zavodny, PJ ;
Hipkin, RW .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :707-715
[9]   EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue [J].
Gräler, MH ;
Bernhardt, G ;
Lipp, M .
GENOMICS, 1998, 53 (02) :164-169
[10]   The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13 [J].
Gräler, MH ;
Grosse, R ;
Kusch, A ;
Kremmer, E ;
Gudermann, T ;
Lipp, M .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (03) :507-519